• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN Back to Search Results
Model Number 6L45-41
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/13/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer obtained a falsely elevated architect total bilirubin result for one patient.Sample id (b)(6) generated 8.49 and repeat 0.21 mg/dl.A serum sample from the same patient was also tested, and generated 0.18 mg/dl.No impact to patient management was reported.
 
Manufacturer Narrative
The evaluation of the customers issue included a review complaint data, trending, lot search and labeling.A review of tickets determined that there is normal complaint activity for lot 56892uq03.Review of trending reports did not identify any issues.Review of manufacturing documentation for the complaint lot found no issues related to the current complaint.Review of product labeling found adequate information to address the complaint issue.The information provided by the customer indicated the same patient sample and a new sample were retested with similar expected lower results.In addition, the qc results were within expected ranges indicating the product is performing as expected.Based on all available information, no systemic issue or deficiency of the architect total bilirubin assay was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL BILIRUBIN
Type of Device
DIAZO COLORIMETRY, BILIRUBIN
Manufacturer (Section D)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
MDR Report Key10771438
MDR Text Key214149257
Report Number3016438761-2020-00279
Device Sequence Number1
Product Code CIG
UDI-Device Identifier00380740011383
UDI-Public00380740011383
Combination Product (y/n)N
PMA/PMN Number
K121985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 11/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2021
Device Model Number6L45-41
Device Catalogue Number06L45-41
Device Lot Number56892UQ03
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 10/14/2020
Initial Date FDA Received11/02/2020
Supplement Dates Manufacturer Received11/04/2020
Supplement Dates FDA Received11/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC C8 PROC MOD, 01G06-11, C804129.; ARC C8 PROC MOD, 01G06-11, C804129.; ARC C8 PROC MOD, 01G06-11, C804129
-
-